Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.07.434227Source: DataRank Database

Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.584. It has been cited 48 times.

N/A

0.584DataRank · unranked

Scored on demand from live citation data

Open Access48 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: greenTopics (27)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.584

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (28)

Yiska Weisblum ORCID,Christopher O. Barnes ORCID,Fabian Schmidt ORCID,Dennis Schaefer-Babajew ORCID,Julio C. C. Lorenzi ORCID

Live enrichment

PubMed:33758864 OpenAlex:https://openalex.org/W3134460024

National Institutes of Health

Grant: 5UL1TR001866-07

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success

National Science Foundation

Grant: 1745301

Graduate Research Fellowship Program (GRFP)

National Institutes of Health

Grant: 8P41GM103393-33

A Synchroton Radiation Structural Biology Resource

National Institutes of Health

Grant: 5R37AI064003-10

Discovery and Mechanism of Antiretroviral Factors

National Institutes of Health

Grant: 5U19AI111825-02

Modulation of Human Dendritic Cell Development by Adjuvants and Vaccines

National Institutes of Health

Grant: 1P01AI138938-01

Epitope-focused vaccine strategies against Zika virus

National Institutes of Health

Grant: 2R01AI078788-12A1

Overcoming Host Restriction Factors to Develop Better Animal Models for HIV/AIDS

National Institutes of Health

Grant: 1K99AI153465-01

Immunization strategies to elicit broadly neutralizing antibodies against HCV

NIAID NIH HHS

Grant: R01 AI078788

NCATS NIH HHS

Grant: UL1 TR001866

NIAID NIH HHS

Grant: P01 AI138938

NIAID NIH HHS

Grant: R37 AI064003

NIAID NIH HHS

Grant: U19 AI111825

NIGMS NIH HHS

Grant: P41 GM103393

NIAID NIH HHS

Grant: K99 AI153465

Influential Citations

Citation Trend

2021

2022

2023

2025

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/03/08/2021.03.07.434227.full.pdf

GREENhttps://www.biorxiv.org/content/biorxiv/early/2021/03/08/2021.03.07.434227.full.pdf

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/03/08/2021.03.07.434227.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.03.07.434227

repositoryhttps://doi.org/10.1101/2021.03.07.434227

Fields of Study

SARS-CoV-2 and COVID-19 ResearchViral Infections and Immunology ResearchMonoclonal and Polyclonal Antibodies ResearchBiologyMedicine0301 basic medicine03 medical and health sciences

Keywords

NeutralizationAntibodyVirologyHeterologousBiologyAffinity maturationNeutralizing antibodyAntigenGerminal centerMutationPotencySomatic cellGeneticsIn vitroB cellGeneSARS-CoV-2, Antibodies, NeutralizationArticleAntibodiesSARS-CoV-2

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies

FAIR Checklist

DataRank Breakdown

Authors (28)

Funding (15 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)